Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Anderson

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Journal of Occupational and Environmental Medicine|August 26, 2014
Do workplace health promotion (wellness) programs work?Ron Z Goetzel, Rachel Mosher Henke, Maryam Tabrizi, et al.
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patientsDavid R Anderson, Gian Paolo Morgano, Carole Bennett, et al.
Blood Advances|May 27, 2020
Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiencesWojtek Wiercioch, Robby Nieuwlaat, Elie A Akl, et al.
Lancet (London, England)|December 10, 2013
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trialSusan R Kahn, Stan Shapiro, Philip S Wells, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Characterization of the dual ITK/JAK3 small molecule covalent inhibitor ATI-2138Aparna Kaul, Heidi Hope, Canxin Xu, et al.
Toxicologic Pathology|May 8, 2010
Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dogDale L Morris, Shawn P O'Neil, Rajesh V Devraj, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Nature|July 3, 2020
A remnant planetary core in the hot-Neptune desertDavid J Armstrong, Théo A Lopez, Vardan Adibekyan, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Journal of Occupational and Environmental Medicine|August 26, 2014
Do workplace health promotion (wellness) programs work?Ron Z Goetzel, Rachel Mosher Henke, Maryam Tabrizi, et al.
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patientsDavid R Anderson, Gian Paolo Morgano, Carole Bennett, et al.
Blood Advances|May 27, 2020
Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiencesWojtek Wiercioch, Robby Nieuwlaat, Elie A Akl, et al.
Lancet (London, England)|December 10, 2013
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trialSusan R Kahn, Stan Shapiro, Philip S Wells, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Characterization of the dual ITK/JAK3 small molecule covalent inhibitor ATI-2138Aparna Kaul, Heidi Hope, Canxin Xu, et al.
Toxicologic Pathology|May 8, 2010
Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dogDale L Morris, Shawn P O'Neil, Rajesh V Devraj, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Nature|July 3, 2020
A remnant planetary core in the hot-Neptune desertDavid J Armstrong, Théo A Lopez, Vardan Adibekyan, et al.
Pageof 15